drug
as of 2026-07-01NRX-1074
at a glance
small molecule
Pre-approval / investigational in the US
Developed by NYU Langone Health
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
NRX-1074 in Early Course Schizophrenia
NCT02603458Phase 2Withdrawn
KOLs & investigators
1
Donald C. Goff, MDKOL score 8
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here